Scopus BioPharma Inc. Profile Avatar - Palmy Investing

Scopus BioPharma Inc.

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers…

Biotechnology
US, New York [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Scopus BioPharma Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Scopus BioPharma Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Scopus BioPharma Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of SCPS's Analysis
CIK: 1772028 CUSIP: 809171101 ISIN: US8091711015 LEI: - UEI: -
Secondary Listings
SCPS has no secondary listings inside our databases.